Analyst Price Target is C$0.55
▲ +∞ Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Spectral Medical in the last 3 months. The average price target is C$0.55, with a high forecast of C$0.55 and a low forecast of C$0.55. The average price target represents a ∞ upside from the last price of C$0.00.
Current Consensus is
The current consensus among 1 polled investment analysts is to buy stock in Spectral Medical.
Standard Diversified, Inc. is a holding company, which owns and operates subsidiaries in a variety of industries, including other tobacco products, insurance, and outdoor advertising. It operates through the following segments: Smokeless Products, Smoking Products, and NewGen Products. The Smokeless Product segment manufactures and markets moist snuff and contracts for and markets chewing tobacco products. The Smoking Products segment imports and markets cigarette papers, tubes, and related products; imports and markets finished cigars, MYO cigar tobaccos, and cigar wraps; and processes, packages, and markets pipe tobaccos. The NewGen Products segment trades e-cigarettes, e-liquids, vaporizers, and other related products; and distributes a wide assortment of vaping products to non-traditional retail outlets via VaporBeast and Vapor Shark. The company was founded by Martha C. Reider, Anne Cavanaugh and Richard C. Birkmeyer in 1990 and is headquartered in New York, NY.